Public annual accounts

JC PHARMA financials

Name: JC PHARMA financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for JC PHARMA, with comparable measures and links to available source documents.

Company overview

Registry number

0460070010

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for JC PHARMA

2025 versus 2024

Operating line: €325,114
EBITDA: €324,965
Total assets: €1,753,214
Equity: €1,213,138

EBITDA margin +100% · Equity ratio +69.2%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€325,114	€324,965	€1,753,214	€1,213,138	-
202431 Dec 2024	€79,474	€78,358	€1,725,241	€997,012	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report